Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-16

Clinical Trial Update: Safety Profile of Nulojix in Home Infusion Settings

View source ↗

Summary

A completed clinical trial evaluating the safety profile of Nulojix (belatacept) when administered in home infusion settings in patients with rheumatoid arthrit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nulojix (belatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Status: COMPLETED